Pharmaceutical Information - November 20, 2008

National Awareness Campaign Underway For Organ Donors

November 3, 2005 - Topics pharmaceutical, surgery, africa, study and transplant
A new study reveals 8 out of 10 African Americans are unaware of the importance of speaking to their loved ones about their wish to become a donor.

In response to the study, The Links, Incorporated and Roche pharmaceutical company will distribute thousands of conversation starter guides at organ donor awareness church events nationwide on National Donor Sabbath, November 13

read more >>

Roche Prepared To Work With Government On Bird Flu Plan

November 1, 2005 - Topics bird flu, flu, influenza, pharmaceutical and fda
After a morning of frightening scenario's played out by President Bush regarding the possibility of an avian flu pandemic, pharmaceutical giant Roche says it is prepared to tackle the virus along with the U.S. Government.

Roche announces it is prepared to supply its antiviral medication Tamiflu for the Strategic National Stockpile, following President Bush's remarks at the National Institutes of Health Tuesday

read more >>

China Requests Tamiflu

November 1, 2005 - Topics tamiflu, bird flu, h5n1, vaccine and europe
China's largest drug maker, Shanghai Pharmaceutical Group, begins talks with Tamiflu maker Roche about making the antiviral drug, thought to be the best defense against a possible flu pandemic.

Roche Holding AG's spokesperson in Shanghai, Xu Chao, says Shanghai Pharmaceutical has been in touch about producing Tamiflu

read more >>

Preliminary Results of Largest Adult ADHD Trial Revealed

October 30, 2005 - Topics child, pharmaceutical, safety, disorder and adderall
Shire Pharmaceuticals Inc. presents new data demonstrating that the drug Adderall XR significantly improves symptoms in adults with Attention-Deficit/Hyperactivity Disorder (ADHD).

Nearly 75-percent of study participants experienced improvement in ADHD symptoms, according to preliminary results of the Quality of Life, Effectiveness, Safety, and Tolerability (Qu.E.S.T.) study, presented at the annual meeting of Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD)

read more >>

Adult ADHD Treatment Rooted in Pediatrics

October 30, 2005 - Topics pharmaceutical, safety, child, adderall and disorder
Shire Pharmaceuticals Inc. unveils new data demonstrating highly prescribed children' drug Adderall significantly improves symptoms in adults with attention deficit-hyperactivity disorder (ADHD).

Nearly 75-percent of study participants experienced improvement in ADHD symptoms, according to preliminary results of the Quality of Life, Effectiveness, Safety, and Tolerability (Qu.E.S.T.) study, presented the data at the annual meeting of Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD)

read more >>





© Copyright 2008 Webmedia Publishing, SA - all rights reserved.     Contact Us  |  Privacy Policy  |  Disclaimer  |  Terms of Use